Our Team
Tim Cloughesy, MD
Co-Founder, CMO
Distinguished Professor, Neurology/Pharmacology, UCLA
Director, Neuro-Oncology Program, UCLA
•Led >100 brain cancer clinical trials
•Principal role in 2 FDA approved drugs for glioma
•Global PI – GBM AGILE
David Nathanson, PhD
Co-Founder, CSO
Professor, Pharmacology, UCLA
Director, Brain Tumor Drug Discovery Program
•Expert in CNS brain tumor translational research and EGFR signaling and therapeutic targeting
•Co-discovered two clinical cancer therapies
Michael Jung, PhD
Co-Founder, SAB
Distinguished Professor, Chemistry and Biochemistry, UCLA
•Co-discovered 2 FDA approved cancer drugs
•Xtandi and Erleada
•Multiple drug candidates in clinical development
Brad Gordon, MBA
President, CEO
Celgene, Signal Pharmaceuticals, Viagene, BIOCOM California
•Built and headed business/corp. development, finance, G&A at multiple VC biotechs
•Start-up, licensing, partnering, M&A expertise